29 May 2026 00:14 CEST
Induct AS
Reference is made to Induct AS' Annual Report for 2025.
The wording in the section "Events after the balance sheet date" regarding the
status of the collaboration with AstraZeneca does not reflect the latest status
as communicated by the company.
Reference is made to the company's Q1 2026 report for a description of the
current status.
This correction does not affect the company's financial statements.
More information:
Access the news on Oslo Bors NewsWeb site
Induct AS
Oslo Børs Newspoint
INDUCT
NO0010536048
INDCT
Euronext Growth
